sildenafil citrate 100mg plus

Lifestyle drugs are medicines that treat conditions attached with lifestyle like weight loss tablets, anti-smoking agents, impotence therapies and hair restorers. According to one statistic, companies have invested over $20 billion in research into such drugs since the 1990s and are expected to increase that amount in the coming years. Because impotence is normally termed as an annoyance rather than a real threat to health, the drugs (in this case Viagra) that treat it are frequently called "lifestyle drugs, though potential new applications could give these compounds lifesaving medical roles in near future. Everyone is talking about Viagra these days. TV shows are interviewing ecstatic customers while newspapers and magazines are analyzing its cultural implications. The internet is spreading information on how to get it, bars and cocktail parties are buzzing with jokes about it. Viagra is more than just a blockbuster drug that treats a widespread sexual ailment, it demonstrates a whole new type of drug that will have bearing on the lifestyle of millions. Viagra is a godsend for men with clinically diagnosed impotence. It is similar to weight loss drugs can be a prominent health boon for the seriously obese. The pivotal factor behind the vast appeal of such drugs is their ability to improve the lives of people with less than severe symptoms. Interestingly, many in the Viagra target audience are sexually potent men who are interested in increasing sexual performance. The new lifestyle drugs could turn the pharmaceutical industry into an engine of growth. Global spending on pharmaceuticals is running at about $300 billion annually. At a time when people lay out $25 to $30 a month on cable television, it seems a distinct possibility that they will be willing to pay as much for a lifestyle drug. Such spending could increase the range of the drug industry in new few years, sending ripple effects through the whole economy. Pfizer's competitors are working overtime to improve on Viagra. The drug started its popularity as a potential angina treatment that, but it also suppressed an important enzyme, giving rise to a firm, sustained erection. The main challenge for competitors of Viagra is to develop medicines that do not produce the side effects of Viagra, which include headache and a blue haze in the patient's vision. The speedy entrance of competing drugs highlights the fact that technology is helping the pharmaceutical industry. Not so long ago, making of new drug would take around 15 years but at present one can make a new drug in the matter of few years. free online order viagra Generic Viagra is a drug used for erectile dysfunctions, or male impotence, and it represents the name for a substance known as sildenafil citrate. The substance is the same, while the market name of the drug may vary and so may its price. Generic versions for many types of drugs have been around for quite some time, but Generic Viagra is a fairly new drug on the market, and it gives men a chance at treating their erectile dysfunctions in an affordable way. Generic Viagra can be expected to have the same effects that the brand name Viagra does, because both drugs have the same active ingredient. Therefore, if your doctor has decided that Viagra is safe for you, it means that you can also use Generic Viagra. How does Generic Viagra work? It increases your ability to have and sustain an erection by inhibiting the enzymes that degrade the cyclic guanosine monophosphate, a substance that facilitates the influx of blood into the penis, by relaxing its spongy tissue. In other words, Viagra dilates blood vessels in the penis, and allows the necessary inflow of blood that an erection requires. Viagra can cause erections only when a man is sexually excited. This is the reason why this drug is not for regular use. It should be taken about one hour before sexual activity, and once the sexual intercourse is over the erection goes away. The efficacy of Generic Viagra has been evaluated based on self-assessment questionnaires, and this evaluation has shown that this drug is responsible for the sexual function improvement of almost ninety percent of those who have used it to treat their erectile dysfunctions. The evaluation included firmness, frequency, and ability to maintain an erection; level and frequency of desire; frequency of orgasm; sexual intercourse satisfaction; and relationship satisfaction. When it comes to the side effects that Generic Viagra can have, it is difficult to anticipate them. Your doctor should be informed shortly after the development of a side effect has occurred, or it has changed its intensity. Some of the side effects of Generic Viagra that are more likely to be experienced by those who use it as treatment include headache, abnormal vision, diarrhea, indigestion, urinary tract infection, and nasal congestion. There are other possible side effects, but these have been experienced at a considerably lower frequency. Remember that it is hard to predict how your body will react to this drug. Chances are that you’ll be just fine, if you don’t have a preexisting condition, such as a heart problem. However, you should inform your doctor about any modification that may occur, and he/she will tell you whether or not you should keep taking Generic Viagra. It is the doctor once again that will give you the most detailed information about the food and drugs Generic Viagra interacts with. It is a well-known fact that erectile dysfunction drugs should not be used simultaneously unless prescribed by a doctor. However, Generic Viagra may interact with other drugs as well, which is why you have to consult with your doctor before taking this medicine. He or she will also inform you about the special warnings that come with this medication, and what conditions do not allow the use of Generic Viagra. 100mg citrate sildenafil Jetlag is defined as a temporary disturbance of the bodily rhythms which is caused by high-speed travel, whether it is on land or on air and across various time zone. This disturbance is usually common in jet aircrafts. People who cross various time zones find it easier to recover from jet lag if the purpose of the travel is for a vacation. This is because when a person travels to a place where he is allowed to relax and recover slowly, it gives him the chance to adjust to the local time of the area. But there are also persons who are not that lucky. People who travel for business purposes usually cross a lot of time zones. When the business traveler reaches his destination he gets busy attending meetings and doing the work that has to be done all based on the local time of that certain place. Thus the business travelers cannot afford the luxury of relaxing and adjusting their bodies to the place's local time. Can Viagra be a relief for jetlag? It is usually not known that there is a certain link between Jetlag and Viagra. A recent study has shown that not only does Viagra treat erectile dysfunction but it can actually also neutralize the effects of jetlag. Viagra has been observed to restore normal bodily clock functions which have been shifted by six hours. Viagra was first developed by Pfizer for aid in treatment of angina and high blood pressure by disturbing the enzyme that causes the reduction of cGMP, a natural compound, cGMP plays a very important in the function of penile erection. In relation to jetlag, cGMP acts in a region of the brain whose role is to regulate the circadian cycle. The circadian cycle is the body's internal clock that determines the waning and the waxing of hormones and also controls the urge to sleep and wake. In a laboratory test, hamsters were injected with Viagra and subjected to bright lights for 6 hours ahead of the regular time. They were observed by a team of researchers from the Universidad Nacional de Quilmes. They found that the injected hamsters have improved in coping with the time difference by 25 to 50 percent as those compared to the hamsters that were not administered with Viagra. The testing gave out a positive result in the light to dark cycle which is the equivalent of traveling from west to east. Further test is needed to really identify the possibility of Viagra as an effective treatment to counter the ill feeling of traveler's jetlag. If this can be validated, then the blue pill can cross the barrier of time and human dysfunction. cheapest sildenafil citrate Are you really positive that ED (erectile dysfunction) is having an effect on your sexual health? Or are you unsure if you have ED? Pfizer have a test for you to take on their website which holds five very important questions to ask yourself. This test only takes two minutes of your time, and may provide you with some good answers. To take the test, head over to and rate your sexual health today. levitra cialis viagra comparison High. Often this involves a sleep-deprived female dragging along her sheepish, snoring partner to see the GP. It's usually linked to variations in jaw and throat anatomy, and is more likely if you tend to sleep on your back. Occasionally, it's caused by polyps blocking your nose. It can be a sign of sleep apnoea, in which breathing is disrupted at night. Can I self-treat? It's a good idea to lose weight and reduce alcohol consumption, if necessary. Various gizmos are available from the chemist or via britishsnoring.co.uk. Is it worth seeing my GP? Yes, if you have a constantly stuffy nose, or sleep apnoea, treatment is available. Astronomical. This symptom seems more at home in a Carry On script than the surgery. If your wind level is off the Beaufort scale, there may be a simple explanation. Causes include fizzy drinks, chewing gum, gulping meals too quickly and the usual food suspects such as beans and broccoli. Air swallowing - via, say, pen-top chewing - may be significant, too. Can I self-treat? Chewing your food more slowly and modifying your diet is more likely to break your wind habit than remedies. Is it worth seeing my GP? Only if there's an underlying cause, which is unusual. Possibilities include excess stomach acid or drug side-effects. Moderate. All things menstrual remain taboo. Usually, this is just a variation of normal. If there's an underlying cause, there may be further clues. Pelvic infection or endometriosis can lead to painful periods and discomfort during sex. Can I self-treat? Yes. Ibuprofen tablets can help to reduce bleeding as well as pain. Is it worth seeing my GP? Yes, if self-treatment doesn't work, or you need contraception - the Pill could help. And there are other options available on prescription. You should also see your doctor if you have other gynaecological symptoms. Very high. Many sufferers feel ashamed and may believe that they smell. Urge incontinence usually results from a “twitchy” bladder and means you can't get to the loo in time. Stress incontinence is caused by weak pelvic-floor muscles leading to leakage on coughing, laughing or straining. Can I self-treat? Urge problems may be eased by gradually training your bladder to accept larger volumes of urine. Stress incontinence may improve with pelvic-floor exercises. Losing excess weight and stopping smoking will help, too. Is it worth seeing my GP? Definitely, if simple measures haven't helped. Treatment depends on the cause, and ranges from tablets to surgery. Moderate. The perceived link with body odour means that sufferers may be reluctant to seek help. This is usually a variation of normal, though stress may be a factor. Occasionally it's caused by an overactive thyroid. Hyperhidrosis is the name given to incredibly drippy armpits or feet. Can I self-treat? Relaxation exercises may help if tension plays a part. For hyperhidrosis, powerful antiperspirants, such as aluminium chloride roll-ons, are available from the chemist. Is it worth seeing my GP? Yes, unless your symptoms are mild and lifelong. A blood test will rule out thyroid trouble. Severe sweating can sometimes be eased by tablets. Lower than previously. Traditionally, this was a “while I'm here” symptom in red-faced males. In the post-Viagra age, they are much happier to discuss ED. These include circulation problems, depression, diabetes, excess alcohol, medication side-effects and psychosexual issues. But usually no specific cause is found. Can I self-treat? Reducing alcohol, stopping smoking and increasing exercise might improve matters, and will at least get you fitter. Avoid “miracle cures” and dodgy supplies of Viagra, though. Is it worth seeing my GP? Yes, unless your ED is recent and easily explained by stress or tiredness. Your doctor will check for any underlying cause, may give you a health MoT and will advise about treatment. High. Pant-area problems always cause awkwardness. This has the added disadvantage of seeming trivial. Typically, no particular reason is found.The itching makes you scratch, which, in turn, aggravates the itch. Sometimes, the symptom is caused by infections such as thrush or threadworms, or by skin problems such as eczema. Can I self-treat? Keep the area squeaky clean, especially after opening your bowels; moisturising tissues will help. And stop scratching. Over-the-counter creams, especially those marketed for “piles”, may make matters worse. Is it worth seeing my GP? Yes, if simple hygiene measures don't work. He can check what's causing the embarrassing itch and prescribe a soothing cream. Very high. There's the squirm-inducing fear that you're turning into a man. This is usually normal. “Unwanted hair” is often a family trait and is more common, for example, in Mediterranean women. Occasionally, it's caused by an underlying illness or the side-effects of tablets. Can I self-treat? Choose from plucking, shaving, waxing, bleaching, depilatory creams, laser treatment or electrolysis. If you're overweight, slimming may help. Is it worth seeing my GP? Certainly, if the hairiness is caused by a medical problem. Clues are a sudden or recent onset, associated scalp hair loss or absent periods - these can be signs of hormonal trouble. GPs may also prescribe creams or tablets for this symptom. High. This is seen as an indictment of personal habits rather than a symptom. The problem may simply be a combination of sweaty feet, less-than-rigorous hygiene and over-dependence on “favourite” shoes. Occasionally, infections cause or aggravate the problem. Can I self-treat? Wear fresh socks daily, clean your feet and the inside of shoes regularly and try washable insoles. Also, avoid wearing trainers every day and let your feet “breathe” whenever possible. Is it worth seeing my GP? Only if you reckon your feet are infected. The clues are scaling of the skin, starting between the toes, or tiny holes or pits dotting your soles. Antifungal creams or antibiotics should clear it up. High. Men aren't supposed to be so vain. Being a man and getting older. Genetics play a part, too, so blame your dad. Can I self-treat? Minoxidil is available as an over-the-counter lotion. It shows limited success in baldness that has been present for only a few years and which mainly affects the crown. Is it worth seeing my GP? Only if you're desperate and minoxidil hasn't helped. The doctor can provide a private prescription for finasteride, a tablet that helps some men. But it can cause side-effects and, like minoxidil, is pricey. It may be more sensible to accept your fate and spend your money on something more worthwhile. Male impotence a problem that virtually every man fears, but at sometime or other in life every man has to confront Erectile Dysfunction (ED). A man’s psychology plays a prominent part in his sexual relationship. If he is depressed, stressed or tense, there is bound to be some impact on his sexual relationship. Anxiety about a man’s sexual routine makes him more stressed and causes his ability to perform to decrease. Erectile Dysfunction can be defined as the inability to have or maintain an erection long enough to have satisfactory sexual intercourse. According to research, ED afflicts nearly 30 million men in America alone and is a cause of great tension. The ideal solution to male sexual impotence issues lies in the little blue pill known as Viagra. Viagra has been quite a handy tool to men who have ED or may be suffering from any degree of male sexual dysfunction. Since the advent of Viagra there has been a great deal of confidence in the patients of erectile dysfunction whether suffering because of the physical or psychological issues. Viagra revives the feeling of self-esteem and manliness, which seems to be lost if you are suffering from ED. Viagra works by enhancing the flow of blood in the penile region and causing a firm erection. The sexual lives of many men have improved because they have the option of Viagra. Viagra can proudly claim to be the first anti-impotence oral pill. The basic chemical base in Viagra is sildenafil citrate. This chemical that treats erectile dysfunction by enabling the man to have an erection long enough to satisfactorily complete sexual intercourse. Many people think that Viagra will enhance their libido or improve their sexual prowess, but this is totally baseless. Viagra can surely be termed as a sex pill, but it is not a libido enhancer drug at all. As a matter of fact, Viagra just acts on the chemicals and enzymes present in your body causing an increased flow of blood in the penis to cause an erection. online viagra prescription There is no foolproof evidence of Viagra not working on women, but according to research carried out on 577 women who had issues with sexual arousal for a time period of at least six months, it has been established that Viagra is not very effective in women. This is because sexual difficulties in women are complex in nature. The women took 10, 50 or 100 milligrams of Viagra one hour before sex for three months. The researchers came to the conclusion that Viagra did not make any sort of difference in terms of greater sexual arousal even though Viagra does enhance blood flow to the woman's genital portion. People are of the view that Viagra does not work on women because they are altogether different from man in terms of their objectives, desires, emotions and at the biochemical level. Female sexuality is quite complex compared to male sexuality so even after wide array of scientific research involving about 3,000 women, Pfizer has not been able to come up with authentic findings. Not so long ago, Pfizer publicly announced in the media that they are completing research of Viagra in women. That does not mean there is no any ray of hope for women. Research is going on continuously in a number of other products for the female libido. Research on postmenopausal women on Viagra has come to the conclusion that the Viagra did have some bearing on the blood flow to the clitoris (quite a number of times uncomfortably so) but did not assist any of the women in getting aroused or feeling more at ease during sex. The multicenter research, which was conducted in Canada, various cities of Europe, and Australia, consists of pre-menopausal and postmenopausal women who have opted for hormone replacement therapy and have been diagnosed with female sexual arousal disorder, a category that falls under the broad umbrella of sexual dysfunction. Interestingly, around twenty eight percent 28% of the women reported hypoactive sexual desire disorder as the main symptom. 17% of the women complained of female orgasmic disorder. 9% women were facing issues due to dyspareunia. A wide array of sexual complaints may have played a prominent role in watering down the effectiveness of Viagra. Only a small chunk of women suffering with sexual dysfunction have poor genital feedback without any issues involving libido or mental arousal. Yet those are the sorts of patients who should get an advantage from taking Viagra. That is where future research will study subgroups of women with arousal disorder, especially those who suffer difficulty in getting extra blood to the front portion of the vagina during sex.
A Revolution of any sort brings with it a new way a life. Viagra, the little blue bill developed for the treatment of erectile dysfunction (ED) has led to a new sexual revolution. This sexual revolution has brought with it a radical change in terms of sexual morality as well as behaviour all around the globe. This is not just another drug; it is the magic bullet that people have been waiting a long time for. Blame it on their nature, men are whimsical creatures who have big egos more and adjudicate their performance on the basis of their sexual prowess. That is where, when men loose their control over sexual ability, they tend to lose their self control. If a man is suffering from ED he is not going to discuss his sex life with anyone, not even with his health care provider. He may even feel embarrassed to talk about it with his mate. Thanks to Viagra, impotence is no longer a taboo issue. Believe it or not, men are coming up openly to discuss and correct their sexual ailment. The sexual revolution attached with Viagra has changed the whole attitude of men’s towards sexuality. With the assistance of Viagra, men are confident that they can satisfy their partner with ease. All in all, their sexual behavior has become more progressive and adventurous. Viagra can restore virility in about 80% of men who have issues, with only minor side effects such as headaches and indigestion. Older medical treatments can leave men with erections that last for more than four hours if sex does not take place. The best part about Viagra is that it only becomes effective when a man is sexually aroused. The drug start making its presence felt when it blocks the operation of an enzyme that plays a prominent role in breaking down the chemical cyclic GMP which is quite important in maintaining erections. Normally, Viagra assisted erections subside after intercourse, a few men have reported that the drug can remain effective for a day. There is no denying that Viagra is fulfilling the requirements of millions of men all around the globe who are suffering from erectile dysfunction by offering them an opportunity to regain their sex lives and lighten up their low self esteem. It assists in infusing freshness in a stale relationship, is a ray of hope for millions of sexually dissatisfied people and has the ability to redefine the meaning of sex and sexuality in your mind and body.

europe online sale viagra

An oral therapy for erectile dysfunction, is the citrate salt of sildenafil, a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Sildenafil citrate is designated chemically as 1 - [[3 - (6,7 - dihydro - 1 - methyl - 7 - oxo - 3 - propyl - 1H - pyrazolo[4,3 - d]pyrimidin - 5 - yl) - 4 - ethoxyphenyl]sulfonyl] - 4 - methylpiperazine citrate and has the following structural formula: Sildenafil citrate is a white to off-white crystalline powder with a solubility of 3.5 mg/mL in water and a molecular weight of 666.7. Viagra (sildenafil citrate) is formulated as blue, film-coated rounded-diamond-shaped tablets equivalent to 25 mg, 50 mg and 100 mg of sildenafil for oral administration. In addition to the active ingredient, sildenafil citrate, each tablet contains the following inactive ingredients: microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide, lactose, triacetin, and FD & C Blue #2 aluminum lake. The physiologic mechanism of erection of the penis involves release of nitric oxide (NO) in the corpus cavernosum during sexual stimulation. NO then activates the enzyme guanylate cyclase, which results in increased levels of cyclic guanosine monophosphate (cGMP), producing smooth muscle relaxation in the corpus cavernosum and allowing inflow of blood. Sildenafil has no direct relaxant effect on isolated human corpus cavernosum, but enhances the effect of nitric oxide (NO) by inhibiting phosphodiesterase type 5 (PDE5), which is responsible for degradation of cGMP in the corpus cavernosum. When sexual stimulation causes local release of NO, inhibition of PDE5 by sildenafil causes increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and inflow of blood to the corpus cavernosum. Sildenafil at recommended doses has no effect in the absence of sexual stimulation. Studies in vitro have shown that sildenafil is selective for PDE5. Its effect is more potent on PDE5 than on other known phosphodiesterases (10-fold for PDE6, >80-fold for PDE1, >700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11). The approximately 4,000-fold selectivity for PDE5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility. Sildenafil is only about 10-fold as potent for PDE5 compared to PDE6, an enzyme found in the retina which is involved in the phototransduction pathway of the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma levels (see ). In addition to human corpus cavernosum smooth muscle, PDE5 is also found in lower concentrations in other tissues including platelets, vascular and visceral smooth muscle, and skeletal muscle. The inhibition of PDE5 in these tissues by sildenafil may be the basis for the enhanced platelet antiaggregatory activity of nitric oxide observed in vitro, an inhibition of platelet thrombus formation in vivo and peripheral arterial-venous dilatation in vivo. Viagra is rapidly absorbed after oral administration, with absolute bioavailability of about 40%. Its pharmacokinetics are dose-proportional over the recommended dose range. It is eliminated predominantly by hepatic metabolism (mainly cytochrome P450 3A4) and is converted to an active metabolite with properties similar to the parent, sildenafil. The concomitant use of potent cytochrome P450 3A4 inhibitors (e.g., erythromycin, ketoconazole, itraconazole) as well as the nonspecific CYP inhibitor, cimetidine, is associated with increased plasma levels of sildenafil (see ). Both sildenafil and the metabolite have terminal half lives of about 4 hours. in Healthy Male Volunteers. Viagra is rapidly absorbed. Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When Viagra is taken with a high fat meal, the rate of absorption is reduced, with a mean delay in T of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues. Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations. Based upon measurements of sildenafil in semen of healthy volunteers 90 minutes after dosing, less than 0.001% of the administered dose may appear in the semen of patients. Sildenafil is cleared predominantly by the CYP3A4 (major route) and CYP2C9 (minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is itself further metabolized. This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. Plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects. After either oral or intravenous administration, sildenafil is excreted as metabolites predominantly in the feces (approximately 80% of administered oral dose) and to a lesser extent in the urine (approximately 13% of the administered oral dose). Similar values for pharmacokinetic parameters were seen in normal volunteers and in the patient population, using a population pharmacokinetic approach. Healthy elderly volunteers (65 years or over) had a reduced clearance of sildenafil, with free plasma concentrations approximately 40% greater than those seen in healthy younger volunteers (18–45 years). In volunteers with mild (CLcr=50–80 mL/min) and moderate (CLcr=30–49 mL/min) renal impairment, the pharmacokinetics of a single oral dose of Viagra (50 mg) were not altered. In volunteers with severe (CLcr=<30 mL/min) renal impairment, sildenafil clearance was reduced, resulting in approximately doubling of AUC and C compared to age-matched volunteers with no renal impairment. In volunteers with hepatic cirrhosis (Child-Pugh A and B), sildenafil clearance was reduced, resulting in increases in AUC (84%) and C (47%) compared to age-matched volunteers with no hepatic impairment. Therefore, age >65, hepatic impairment and severe renal impairment are associated with increased plasma levels of sildenafil. A starting oral dose of 25 mg should be considered in those patients (see ). In eight double-blind, placebo-controlled crossover studies of patients with either organic or psychogenic erectile dysfunction, sexual stimulation resulted in improved erections, as assessed by an objective measurement of hardness and duration of erections (RigiScan ), after Viagra administration compared with placebo. Most studies assessed the efficacy of Viagra approximately 60 minutes post dose. The erectile response, as assessed by RigiScan , generally increased with increasing sildenafil dose and plasma concentration. The time course of effect was examined in one study, showing an effect for up to 4 hours but the response was diminished compared to 2 hours. Single oral doses of sildenafil (100 mg) administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8.4/5.5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was not different than placebo at 8 hours. Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg of Viagra, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving concomitant nitrates (see ). Systolic Blood Pressure, Healthy Volunteers. Single oral doses of sildenafil up to 100 mg produced no clinically relevant changes in the ECGs of normal male volunteers. Studies have produced relevant data on the effects of Viagra on cardiac output. In one small, open-label, uncontrolled, pilot study, eight patients with stable ischemic heart disease underwent Swan-Ganz catheterization. A total dose of 40 mg sildenafil was administered by four intravenous infusions. The results from this pilot study are shown in Table 1; the mean resting systolic and diastolic blood pressures decreased by 7% and 10% compared to baseline in these patients. Mean resting values for right atrial pressure, pulmonary artery pressure, pulmonary artery occluded pressure and cardiac output decreased by 28%, 28%, 20% and 7% respectively. Even though this total dosage produced plasma sildenafil concentrations which were approximately 2 to 5 times higher than the mean maximum plasma concentrations following a single oral dose of 100 mg in healthy male volunteers, the hemodynamic response to exercise was preserved in these patients. In a double-blind study, 144 patients with erectile dysfunction and chronic stable angina limited by exercise, not receiving chronic oral nitrates, were randomized to a single dose of placebo or Viagra 100 mg 1 hour prior to exercise testing. The primary endpoint was time to limiting angina in the evaluable cohort. The mean times (adjusted for baseline) to onset of limiting angina were 423.6 and 403.7 seconds for sildenafil (N=70) and placebo, respectively. These results demonstrated that the effect of Viagra on the primary endpoint was statistically non-inferior to placebo. At single oral doses of 100 mg and 200 mg, transient dose-related impairment of color discrimination (blue/green) was detected using the Farnsworth-Munsell 100-hue test, with peak effects near the time of peak plasma levels. This finding is consistent with the inhibition of PDE6, which is involved in phototransduction in the retina. An evaluation of visual function at doses up to twice the maximum recommended dose revealed no effects of Viagra on visual acuity, intraocular pressure, or pupillometry. In clinical studies, Viagra was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. Viagra was evaluated primarily at doses of 25 mg, 50 mg and 100 mg in 21 randomized, double-blind, placebo-controlled trials of up to 6 months in duration, using a variety of study designs (fixed dose, titration, parallel, crossover). Viagra was administered to more than 3,000 patients aged 19 to 87 years, with ED of various etiologies (organic, psychogenic, mixed) with a mean duration of 5 years. Viagra demonstrated statistically significant improvement compared to placebo in all 21 studies. The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo. The effectiveness of Viagra was evaluated in most studies using several assessment instruments. The primary measure in the principal studies was a sexual function questionnaire (the International Index of Erectile Function - IIEF) administered during a 4-week treatment-free run-in period, at baseline, at follow-up visits, and at the end of double-blind, placebo-controlled, at-home treatment. Two of the questions from the IIEF served as primary study endpoints; categorical responses were elicited to questions about (1) the ability to achieve erections sufficient for sexual intercourse and (2) the maintenance of erections after penetration. The patient addressed both questions at the final visit for the last 4 weeks of the study. The possible categorical responses to these questions were (0) no attempted intercourse, (1) never or almost never, (2) a few times, (3) sometimes, (4) most times, and (5) almost always or always. Also collected as part of the IIEF was information about other aspects of sexual function, including information on erectile function, orgasm, desire, satisfaction with intercourse, and overall sexual satisfaction. Sexual function data were also recorded by patients in a daily diary. In addition, patients were asked a global efficacy question and an optional partner questionnaire was administered. The effect on one of the major end points, maintenance of erections after penetration, is shown in Figure 3, for the pooled results of 5 fixed-dose, dose-response studies of greater than one month duration, showing response according to baseline function. Results with all doses have been pooled, but scores showed greater improvement at the 50 and 100 mg doses than at 25 mg. The pattern of responses was similar for the other principal question, the ability to achieve an erection sufficient for intercourse. The titration studies, in which most patients received 100 mg, showed similar results. Figure 3 shows that regardless of the baseline levels of function, subsequent function in patients treated with Viagra was better than that seen in patients treated with placebo. At the same time, on-treatment function was better in treated patients who were less impaired at baseline. Figure 3. Effect of Viagra and Placebo on Maintenance of Erection by Baseline Score. The frequency of patients reporting improvement of erections in response to a global question in four of the randomized, double-blind, parallel, placebo-controlled fixed dose studies (1797 patients) of 12 to 24 weeks duration is shown in Figure 4. These patients had erectile dysfunction at baseline that was characterized by median categorical scores of 2 (a few times) on principal IIEF questions. Erectile dysfunction was attributed to organic (58%; generally not characterized, but including diabetes and excluding spinal cord injury), psychogenic (17%), or mixed (24%) etiologies. Sixty-three percent, 74%, and 82% of the patients on 25 mg, 50 mg and 100 mg of Viagra, respectively, reported an improvement in their erections, compared to 24% on placebo. In the titration studies (n=644) (with most patients eventually receiving 100 mg), results were similar. Figure 4. Percentage of Patients Reporting an Improvement in Erections. The patients in studies had varying degrees of ED. One-third to one-half of the subjects in these studies reported successful intercourse at least once during a 4-week, treatment-free run-in period. In many of the studies, of both fixed dose and titration designs, daily diaries were kept by patients. In these studies, involving about 1600 patients, analyses of patient diaries showed no effect of Viagra on rates of attempted intercourse (about 2 per week), but there was clear treatment-related improvement in sexual function: per patient weekly success rates averaged 1.3 on 50–100 mg of Viagra vs 0.4 on placebo; similarly, group mean success rates (total successes divided by total attempts) were about 66% on Viagra vs about 20% on placebo. During 3 to 6 months of double-blind treatment or longer-term (1 year), open-label studies, few patients withdrew from active treatment for any reason, including lack of effectiveness. At the end of the long-term study, 88% of patients reported that Viagra improved their erections. Men with untreated ED had relatively low baseline scores for all aspects of sexual function measured (again using a 5-point scale) in the IIEF. Viagra improved these aspects of sexual function: frequency, firmness and maintenance of erections; frequency of orgasm; frequency and level of desire; frequency, satisfaction and enjoyment of intercourse; and overall relationship satisfaction. One randomized, double-blind, flexible-dose, placebo-controlled study included only patients with erectile dysfunction attributed to complications of diabetes mellitus (n=268). As in the other titration studies, patients were started on 50 mg and allowed to adjust the dose up to 100 mg or down to 25 mg of Viagra; all patients, however, were receiving 50 mg or 100 mg at the end of the study. There were highly statistically significant improvements on the two principal IIEF questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) on Viagra compared to placebo. On a global improvement question, 57% of Viagra patients reported improved erections versus 10% on placebo. Diary data indicated that on Viagra, 48% of intercourse attempts were successful versus 12% on placebo. One randomized, double-blind, placebo-controlled, crossover, flexible-dose (up to 100 mg) study of patients with erectile dysfunction resulting from spinal cord injury (n=178) was conducted. The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of Viagra. On a global improvement question, 83% of patients reported improved erections on Viagra versus 12% on placebo. Diary data indicated that on Viagra, 59% of attempts at sexual intercourse were successful compared to 13% on placebo. Across all trials, Viagra improved the erections of 43% of radical prostatectomy patients compared to 15% on placebo. Subgroup analyses of responses to a global improvement question in patients with psychogenic etiology in two fixed-dose studies (total n=179) and two titration studies (total n=149) showed 84% of Viagra patients reported improvement in erections compared with 26% of placebo. The changes from baseline in scoring on the two end point questions (frequency of successful penetration during sexual activity and maintenance of erections after penetration) were highly statistically significantly in favor of Viagra. Diary data in two of the studies (n=178) showed rates of successful intercourse per attempt of 70% for Viagra and 29% for placebo. A review of population subgroups demonstrated efficacy regardless of baseline severity, etiology, race and age. Viagra was effective in a broad range of ED patients, including those with a history of coronary artery disease, hypertension, other cardiac disease, peripheral vascular disease, diabetes mellitus, depression, coronary artery bypass graft (CABG), radical prostatectomy, transurethral resection of the prostate (TURP) and spinal cord injury, and in patients taking antidepressants/antipsychotics and antihypertensives/diuretics. Analysis of the safety database showed no apparent difference in the side effect profile in patients taking Viagra with and without antihypertensive medication. This analysis was performed retrospectively, and was not powered to detect any pre-specified difference in adverse reactions. Viagra is indicated for the treatment of erectile dysfunction. ), Viagra was shown to potentiate the hypotensive effects of nitrates, and its administration to patients who are using organic nitrates, either regularly and/or intermittently, in any form is therefore contraindicated. After patients have taken Viagra, it is unknown when nitrates, if necessary, can be safely administered. Based on the pharmacokinetic profile of a single 100 mg oral dose given to healthy normal volunteers, the plasma levels of sildenafil at 24 hours post dose are approximately 2 ng/mL (compared to peak plasma levels of approximately 440 ng/mL) (see ). In the following patients: age >65, hepatic impairment (e.g., cirrhosis), severe renal impairment (e.g., creatinine clearance <30 mL/min), and concomitant use of potent cytochrome P450 3A4 inhibitors (erythromycin), plasma levels of sildenafil at 24 hours post dose have been found to be 3 to 8 times higher than those seen in healthy volunteers. Although plasma levels of sildenafil at 24 hours post dose are much lower than at peak concentration, it is unknown whether nitrates can be safely coadministered at this time point. Viagra is contraindicated in patients with a known hypersensitivity to any component of the tablet. There is a potential for cardiac risk of sexual activity in patients with preexisting cardiovascular disease. Therefore, treatments for erectile dysfunction, including Viagra, should not be generally used in men for whom sexual activity is inadvisable because of their underlying cardiovascular status. Viagra has systemic vasodilatory properties that resulted in transient decreases in supine blood pressure in healthy volunteers (mean maximum decrease of 8.4/5.5 mmHg), (see ). While this normally would be expected to be of little consequence in most patients, prior to prescribing Viagra, physicians should carefully consider whether their patients with underlying cardiovascular disease could be affected adversely by such vasodilatory effects, especially in combination with sexual activity. Patients with the following underlying conditions can be particularly sensitive to the actions of vasodilators including Viagra – those with left ventricular outflow obstruction (e.g. aortic stenosis, idiopathic hypertrophic subaortic stenosis) and those with severely impaired autonomic control of blood pressure. There is no controlled clinical data on the safety or efficacy of Viagra in the following groups; if prescribed, this should be done with caution. Patients who have suffered a myocardial infarction, stroke, or life-threatening arrhythmia within the last 6 months; Patients with retinitis pigmentosa (a minority of these patients have genetic disorders of retinal phosphodiesterases). Prolonged erection greater than 4 hours and priapism (painful erections greater than 6 hours in duration) have been reported infrequently since market approval of Viagra. In the event of an erection that persists longer than 4 hours, the patient should seek immediate medical assistance. If priapism is not treated immediately, penile tissue damage and permanent loss of potency could result. The concomitant administration of the protease inhibitor ritonavir substantially increases serum concentrations of sildenafil (11-fold increase in AUC). If Viagra is prescribed to patients taking ritonavir, caution should be used. Data from subjects exposed to high systemic levels of sildenafil are limited. Visual disturbances occurred more commonly at higher levels of sildenafil exposure. Decreased blood pressure, syncope, and prolonged erection were reported in some healthy volunteers exposed to high doses of sildenafil (200–800 mg). To decrease the chance of adverse events in patients taking ritonavir, a decrease in sildenafil dosage is recommended (see , ). The evaluation of erectile dysfunction should include a determination of potential underlying causes and the identification of appropriate treatment following a complete medical assessment. Before prescribing Viagra, it is important to note the following: Caution is advised when Phosphodiesterase Type 5 (PDE5) inhibitors are co-administered with alpha-blockers. PDE5 inhibitors, including Viagra, and alpha-adrenergic blocking agents are both vasodilators with blood pressure lowering effects. When vasodilators are used in combination, an additive effect on blood pressure may be anticipated. In some patients, concomitant use of these two drug classes can lower blood pressure significantly (see ) leading to symptomatic hypotension (e.g. dizziness, lightheadedness, fainting). Patients should be stable on alpha-blocker therapy prior to initiating a PDE5 inhibitor. Patients who demonstrate hemodynamic instability on alpha-blocker therapy alone are at increased risk of symptomatic hypotension with concomitant use of PDE5 inhibitors. In those patients who are stable on alpha-blocker therapy, PDE5 inhibitors should be initiated at the lowest dose. In those patients already taking an optimized dose of a PDE5 inhibitor, alpha-blocker therapy should be initiated at the lowest dose. Stepwise increase in alpha-blocker dose may be associated with further lowering of blood pressure when taking a PDE5 inhibitor. Safety of combined use of PDE5 inhibitors and alpha-blockers may be affected by other variables, including intravascular volume depletion and other anti-hypertensive drugs. Viagra has systemic vasodilatory properties and may augment the blood pressure lowering effect of other anti-hypertensive medications. Patients on multiple antihypertensive medications were included in the pivotal clinical trials for Viagra. In a separate drug interaction study, when amlodipine, 5 mg or 10 mg, and Viagra, 100 mg were orally administered concomitantly to hypertensive patients mean additional blood pressure reduction of 8 mmHg systolic and 7 mmHg diastolic were noted (see ). The safety of Viagra is unknown in patients with bleeding disorders and patients with active peptic ulceration. Viagra should be used with caution in patients with anatomical deformation of the penis (such as angulation, cavernosal fibrosis or Peyronie's disease), or in patients who have conditions which may predispose them to priapism (such as sickle cell anemia, multiple myeloma, or leukemia). The safety and efficacy of combinations of Viagra with other treatments for erectile dysfunction have not been studied. Therefore, the use of such combinations is not recommended. In humans, Viagra has no effect on bleeding time when taken alone or with aspirin. In vitro studies with human platelets indicate that sildenafil potentiates the antiaggregatory effect of sodium nitroprusside (a nitric oxide donor). The combination of heparin and Viagra had an additive effect on bleeding time in the anesthetized rabbit, but this interaction has not been studied in humans. Physicians should discuss with patients the contraindication of Viagra with regular and/or intermittent use of organic nitrates. Physicians should advise patients of the potential for Viagra to augment the blood pressure lowering effect of alpha-blockers and anti-hypertensive medications. Concomitant administration of Viagra and an alpha-blocker may lead to symptomatic hypotension in some patients. Therefore, when Viagra is co-administered with alpha-blockers, patients should be stable on alpha-blocker therapy prior to initiating Viagra treatment and Viagra should be initiated at the lowest dose. Physicians should discuss with patients the potential cardiac risk of sexual activity in patients with preexisting cardiovascular risk factors. Patients who experience symptoms (e.g., angina pectoris, dizziness, nausea) upon initiation of sexual activity should be advised to refrain from further activity and should discuss the episode with their physician. Physicians should advise patients to stop use of all PDE5 inhibitors, including Viagra, and seek medical attention in the event of a sudden loss of vision in one or both eyes. Such an event may be a sign of non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, that has been reported rarely post-marketing in temporal association with the use of all PDE5 inhibitors. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors. Physicians should also discuss with patients the increased risk of NAION in individuals who have already experienced NAION in one eye, including whether such individuals could be adversely affected by use of vasodilators, such as PDE5 inhibitors (see ). Physicians should advise patients to stop taking PDE5 inhibitors, including Viagra, and seek prompt medical attention in the event of sudden decrease or loss of hearing. These events, which may be accompanied by tinnitus and dizziness, have been reported in temporal association to the intake of PDE5 inhibitors, including Viagra. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors or to other factors (see , ). Physicians should warn patients that prolonged erections greater than 4 hours and priapism (painful erections greater than 6 hours in duration) have been reported infrequently since market approval of Viagra. In the event of an erection that persists longer than 4 hours, the patient should seek immediate medical assistance. If priapism is not treated immediately, penile tissue damage and permanent loss of potency may result. The use of Viagra offers no protection against sexually transmitted diseases. Counseling of patients about the protective measures necessary to guard against sexually transmitted diseases, including the Human Immunodeficiency Virus (HIV), may be considered. Sildenafil metabolism is principally mediated by the cytochrome P450 (CYP) isoforms 3A4 (major route) and 2C9 (minor route). Therefore, inhibitors of these isoenzymes may reduce sildenafil clearance. Cimetidine (800 mg), a nonspecific CYP inhibitor, caused a 56% increase in plasma sildenafil concentrations when coadministered with Viagra (50 mg) to healthy volunteers. When a single 100 mg dose of Viagra was administered with erythromycin, a specific CYP3A4 inhibitor, at steady state (500 mg bid for 5 days), there was a 182% increase in sildenafil systemic exposure (AUC). In addition, in a study performed in healthy male volunteers, coadministration of the HIV protease inhibitor saquinavir, also a CYP3A4 inhibitor, at steady state (1200 mg tid) with Viagra (100 mg single dose) resulted in a 140% increase in sildenafil C and a 210% increase in sildenafil AUC. Viagra had no effect on saquinavir pharmacokinetics. Stronger CYP3A4 inhibitors such as ketoconazole or itraconazole would be expected to have still greater effects, and population data from patients in clinical trials did indicate a reduction in sildenafil clearance when it was coadministered with CYP3A4 inhibitors (such as ketoconazole, erythromycin, or cimetidine) (see ). In another study in healthy male volunteers, coadministration with the HIV protease inhibitor ritonavir, which is a highly potent P450 inhibitor, at steady state (500 mg bid) with Viagra (100 mg single dose) resulted in a 300% (4-fold) increase in sildenafil C and a 1000% (11-fold) increase in sildenafil plasma AUC. At 24 hours the plasma levels of sildenafil were still approximately 200 ng/mL, compared to approximately 5 ng/mL when sildenafil was dosed alone. This is consistent with ritonavir's marked effects on a broad range of P450 substrates. Viagra had no effect on ritonavir pharmacokinetics (see ). Although the interaction between other protease inhibitors and sildenafil has not been studied, their concomitant use is expected to increase sildenafil levels. In a study of healthy male volunteers, co-administration of sildenafil at steady state (80 mg t.i.d.) with endothelin receptor antagonist bosentan (a moderate inducer of CYP3A4, CYP2C9 and possibly of cytochrome P450 2C19) at steady state (125 mg b.i.d.) resulted in a 63% decrease of sildenafil AUC and a 55% decrease in sildenafil C . Concomitant administration of strong CYP3A4 inducers, such as rifampin, is expected to cause greater decreases in plasma levels of sildenafil. Single doses of antacid (magnesium hydroxide/aluminum hydroxide) did not affect the bioavailability of Viagra. Pharmacokinetic data from patients in clinical trials showed no effect on sildenafil pharmacokinetics of CYP2C9 inhibitors (such as tolbutamide, warfarin), CYP2D6 inhibitors (such as selective serotonin reuptake inhibitors, tricyclic antidepressants), thiazide and related diuretics, ACE inhibitors, and calcium channel blockers. The AUC of the active metabolite, N-desmethyl sildenafil, was increased 62% by loop and potassium-sparing diuretics and 102% by nonspecific beta-blockers. These effects on the metabolite are not expected to be of clinical consequence. Sildenafil is a weak inhibitor of the cytochrome P450 isoforms 1A2, 2C9, 2C19, 2D6, 2E1 and 3A4 (IC50 >150 µM). Given sildenafil peak plasma concentrations of approximately 1 µM after recommended doses, it is unlikely that Viagra will alter the clearance of substrates of these isoenzymes. Three double-blind, placebo-controlled, randomized, two-way crossover studies were conducted to assess the interaction of Viagra with doxazosin, an alpha-adrenergic blocking agent. In the first study, a single oral dose of Viagra 100 mg or matching placebo was administered in a 2-period crossover design to 4 generally healthy males with benign prostatic hyperplasia (BPH). Following at least 14 consecutive daily doses of doxazosin, Viagra 100 mg or matching placebo was administered simultaneously with doxazosin. Following a review of the data from these first 4 subjects (details provided below), the Viagra dose was reduced to 25 mg. Thereafter, 17 subjects were treated with Viagra 25 mg or matching placebo in combination with doxazosin 4 mg (15 subjects) or doxazosin 8mg (2 subjects). The mean subject age was 66.5 years. For the 17 subjects who received Viagra 25 mg and matching placebo, the placebo-subtracted mean maximum decreases from baseline (95% CI) in systolic blood pressure were as follows: Blood pressure was measured immediately pre-dose and at 15, 30, 45 minutes, and 1, 1.5, 2, 2.5, 3, 4, 6 and 8 hours after Viagra or matching placebo. Outliers were defined as subjects with a standing systolic blood pressure of <85 mmHg or a decrease from baseline in standing systolic blood pressure of >30 mmHg at one or more timepoints. There were no subjects treated with Viagra 25 mg who had a standing SBP < 85mmHg. There were three subjects with a decrease from baseline in standing systolic BP >30mmHg following Viagra 25 mg, one subject with a decrease from baseline in standing systolic BP > 30 mmHg following placebo and two subjects with a decrease from baseline in standing systolic BP > 30 mmHg following both Viagra and placebo. No severe adverse events potentially related to blood pressure effects were reported in this group. Of the four subjects who received Viagra 100 mg in the first part of this study, a severe adverse event related to blood pressure effect was reported in one patient (postural hypotension that began 35 minutes after dosing with Viagra with symptoms lasting for 8 hours), and mild adverse events potentially related to blood pressure effects were reported in two others (dizziness, headache and fatigue at 1 hour after dosing; and dizziness, lightheadedness and nausea at 4 hours after dosing). There were no reports of syncope among these patients. For these four subjects, the placebo-subtracted mean maximum decreases from baseline in supine and standing systolic blood pressures were 14.8 mmHg and 21.5 mmHg, respectively. Two of these subjects had a standing SBP < 85mmHg. Both of these subjects were protocol violators, one due to a low baseline standing SBP, and the other due to baseline orthostatic hypotension. In the second study, a single oral dose of Viagra 50 mg or matching placebo was administered in a 2-period crossover design to 20 generally healthy males with BPH. Following at least 14 consecutive days of doxazosin, Viagra 50mg or matching placebo was administered simultaneously with doxazosin 4 mg (17 subjects) or with doxazosin 8 mg (3 subjects). The mean subject age in this study was 63.9 years. Twenty subjects received Viagra 50 mg, but only 19 subjects received matching placebo. One patient discontinued the study prematurely due to an adverse event of hypotension following dosing with Viagra 50 mg. This patient had been taking minoxidil, a potent vasodilator, during the study. For the 19 subjects who received both Viagra and matching placebo, the placebo-subtracted mean maximum decreases from baseline (95% CI) in systolic blood pressure were as follows: Blood pressure was measured after administration of Viagra at the same times as those specified for the first doxazosin study. There were two subjects who had a standing SBP of < 85 mmHg. In these two subjects, hypotension was reported as a moderately severe adverse event, beginning at approximately 1 hour after administration of Viagra 50 mg and resolving after approximately 7.5 hours. There was one subject with a decrease from baseline in standing systolic BP >30mmHg following Viagra 50 mg and one subject with a decrease from baseline in standing systolic BP > 30 mmHg following both Viagra 50 mg and placebo. There were no severe adverse events potentially related to blood pressure and no episodes of syncope reported in this study. In the third study, a single oral dose of Viagra 100 mg or matching placebo was administered in a 3-period crossover design to 20 generally healthy males with BPH. In dose period 1, subjects were administered open-label doxazosin and a single dose of Viagra 50 mg simultaneously, after at least 14 consecutive days of doxazosin. If a subject did not successfully complete this first dosing period, he was discontinued from the study. Subjects who had successfully completed the previous doxazosin interaction study (using Viagra 50 mg), including no significant hemodynamic adverse events, were allowed to skip dose period 1. Treatment with doxazosin continued for at least 7 days after dose period 1. Thereafter, Viagra 100mg or matching placebo was administered simultaneously with doxazosin 4 mg (14 subjects) or doxazosin 8 mg (6 subjects) in standard crossover fashion. The mean subject age in this study was 66.4 years. Twenty-five subjects were screened. Two were discontinued after study period 1: one failed to meet pre-dose screening qualifications and the other experienced symptomatic hypotension as a moderately severe adverse event 30 minutes after dosing with open-label Viagra 50 mg. Of the twenty subjects who were ultimately assigned to treatment, a total of 13 subjects successfully completed dose period 1, and seven had successfully completed the previous doxazosin study (using Viagra 50 mg). For the 20 subjects who received Viagra 100 mg and matching placebo, the placebo-subtracted mean maximum decreases from baseline (95% CI) in systolic blood pressure were as follows: Blood pressure was measured after administration of Viagra at the same times as those specified for the previous doxazosin studies. There were three subjects who had a standing SBP of < 85 mmHg. All three were taking Viagra 100 mg, and all three reported mild adverse events at the time of reductions in standing SBP, including vasodilation and lightheadedness. There were four subjects with a decrease from baseline in standing systolic BP >30mmHg following Viagra 100 mg, one subject with a decrease from baseline in standing systolic BP > 30 mmHg following placebo and one subject with a decrease from baseline in standing systolic BP > 30 mmHg following both Viagra and placebo. While there were no severe adverse events potentially related to blood pressure reported in this study, one subject reported moderate vasodilatation after both Viagra 50 mg and 100 mg. There were no episodes of syncope reported in this study. When Viagra 100 mg oral was coadministered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic. No significant interactions were shown with tolbutamide (250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9. Viagra (50 mg) did not potentiate the increase in bleeding time caused by aspirin (150 mg). Viagra (50 mg) did not potentiate the hypotensive effect of alcohol in healthy volunteers with mean maximum blood alcohol levels of 0.08%. In a study of healthy male volunteers, sildenafil (100 mg) did not affect the steady state pharmacokinetics of the HIV protease inhibitors, saquinavir and ritonavir, both of which are CYP3A4 substrates. Sildenafil at steady state (80 mg t.i.d.) resulted in a 50% increase in AUC and a 42% increase in C of bosentan (125 mg b.i.d.). Carcinogenesis, Mutagenesis, Impairment of Fertility Sildenafil was not carcinogenic when administered to rats for 24 months at a dose resulting in total systemic drug exposure (AUCs) for unbound sildenafil and its major metabolite of 29- and 42-times, for male and female rats, respectively, the exposures observed in human males given the Maximum Recommended Human Dose (MRHD) of 100 mg. Sildenafil was not carcinogenic when administered to mice for 18–21 months at dosages up to the Maximum Tolerated Dose (MTD) of 10 mg/kg/day, approximately 0.6 times the MRHD on a mg/m basis. Sildenafil was negative in in vitro bacterial and Chinese hamster ovary cell assays to detect mutagenicity, and in vitro human lymphocytes and in vivo mouse micronucleus assays to detect clastogenicity. There was no impairment of fertility in rats given sildenafil up to 60 mg/kg/day for 36 days to females and 102 days to males, a dose producing an AUC value of more than 25 times the human male AUC. There was no effect on sperm motility or morphology after single 100 mg oral doses of Viagra in healthy volunteers. Pregnancy, Nursing Mothers and Pediatric Use Viagra is not indicated for use in newborns, children, or women. No evidence of teratogenicity, embryotoxicity or fetotoxicity was observed in rats and rabbits which received up to 200 mg/kg/day during organogenesis. These doses represent, respectively, about 20 and 40 times the MRHD on a mg/m basis in a 50 kg subject. In the rat pre- and postnatal development study, the no observed adverse effect dose was 30 mg/kg/day given for 36 days. In the nonpregnant rat the AUC at this dose was about 20 times human AUC. There are no adequate and well-controlled studies of sildenafil in pregnant women. ). Since higher plasma levels may increase both the efficacy and incidence of adverse events, a starting dose of 25 mg should be considered (see ). Viagra was administered to over 3700 patients (aged 19–87 years) during pre-marketing clinical trials worldwide. Over 550 patients were treated for longer than one year. In placebo-controlled clinical studies, the discontinuation rate due to adverse events for Viagra (2.5%) was not significantly different from placebo (2.3%). The adverse events were generally transient and mild to moderate in nature. In trials of all designs, adverse events reported by patients receiving Viagra were generally similar. In fixed-dose studies, the incidence of some adverse events increased with dose. The nature of the adverse events in flexible-dose studies, which more closely reflect the recommended dosage regimen, was similar to that for fixed-dose studies. When Viagra was taken as recommended (on an as-needed basis) in flexible-dose, placebo-controlled clinical trials, the following adverse events were reported: Other adverse reactions occurred at a rate of >2%, but equally common on placebo: respiratory tract infection, back pain, flu syndrome, and arthralgia. In fixed-dose studies, dyspepsia (17%) and abnormal vision (11%) were more common at 100 mg than at lower doses. At doses above the recommended dose range, adverse events were similar to those detailed above but generally were reported more frequently. The following events occurred in <2% of patients in controlled clinical trials; a causal relationship to Viagra is uncertain. Reported events include those with a plausible relation to drug use; omitted are minor events and reports too imprecise to be meaningful: Body as a whole: face edema, photosensitivity reaction, shock, asthenia, pain, chills, accidental fall, abdominal pain, allergic reaction, chest pain, accidental injury. Cardiovascular: angina pectoris, AV block, migraine, syncope, tachycardia, palpitation, hypotension, postural hypotension, myocardial ischemia, cerebral thrombosis, cardiac arrest, heart failure, abnormal electrocardiogram, cardiomyopathy. Digestive: vomiting, glossitis, colitis, dysphagia, gastritis, gastroenteritis, esophagitis, stomatitis, dry mouth, liver function tests abnormal, rectal hemorrhage, gingivitis. Hemic and Lymphatic: anemia and leukopenia. Metabolic and Nutritional: thirst, edema, gout, unstable diabetes, hyperglycemia, peripheral edema, hyperuricemia, hypoglycemic reaction, hypernatremia. Musculoskeletal: arthritis, arthrosis, myalgia, tendon rupture, tenosynovitis, bone pain, myasthenia, synovitis. Nervous: ataxia, hypertonia, neuralgia, neuropathy, paresthesia, tremor, vertigo, depression, insomnia, somnolence, abnormal dreams, reflexes decreased, hypesthesia. Respiratory: asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, sputum increased, cough increased. Skin and Appendages: urticaria, herpes simplex, pruritus, sweating, skin ulcer, contact dermatitis, exfoliative dermatitis. Special Senses: sudden decrease or loss of hearing, mydriasis, conjunctivitis, photophobia, tinnitus, eye pain, ear pain, eye hemorrhage, cataract, dry eyes. Urogenital: cystitis, nocturia, urinary frequency, breast enlargement, urinary incontinence, abnormal ejaculation, genital edema and anorgasmia. Serious cardiovascular, cerebrovascular, and vascular events, including myocardial infarction, sudden cardiac death, ventricular arrhythmia, cerebrovascular hemorrhage, transient ischemic attack, hypertension, subarachnoid and intracerebral hemorrhages, and pulmonary hemorrhage have been reported post-marketing in temporal association with the use of Viagra. Most, but not all, of these patients had preexisting cardiovascular risk factors. Many of these events were reported to occur during or shortly after sexual activity, and a few were reported to occur shortly after the use of Viagra without sexual activity. Others were reported to have occurred hours to days after the use of Viagra and sexual activity. It is not possible to determine whether these events are related directly to Viagra, to sexual activity, to the patient's underlying cardiovascular disease, to a combination of these factors, or to other factors (see for further important cardiovascular information). Cases of sudden decrease or loss of hearing have been reported postmarketing in temporal association with the use of PDE5 inhibitors, including Viagra. In some of the cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of Viagra, to the patient’s underlying risk factors for hearing loss, a combination of these factors, or to other factors (see ). Nervous: seizure and anxiety. Urogenital: prolonged erection, priapism (see ), and hematuria. Special Senses: diplopia, temporary vision loss/decreased vision, ocular redness or bloodshot appearance, ocular burning, ocular swelling/pressure, increased intraocular pressure, retinal vascular disease or bleeding, vitreous detachment/traction, paramacular edema and epistaxis. Non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported rarely post-marketing in temporal association with the use of phosphodiesterase type 5 (PDE5) inhibitors, including Viagra. Most, but not all, of these patients had underlying anatomic or vascular risk factors for developing NAION, including but not necessarily limited to: low cup to disc ratio ("crowded disc"), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors, to the patient's underlying vascular risk factors or anatomical defects, to a combination of these factors, or to other factors (see ). In studies with healthy volunteers of single doses up to 800 mg, adverse events were similar to those seen at lower doses but incidence rates were increased. In cases of overdose, standard supportive measures should be adopted as required. Renal dialysis is not expected to accelerate clearance as sildenafil is highly bound to plasma proteins and it is not eliminated in the urine. For most patients, the recommended dose is 50 mg taken, as needed, approximately 1 hour before sexual activity. However, Viagra may be taken anywhere from 4 hours to 0.5 hour before sexual activity. Based on effectiveness and toleration, the dose may be increased to a maximum recommended dose of 100 mg or decreased to 25 mg. The maximum recommended dosing frequency is once per day. The following factors are associated with increased plasma levels of sildenafil: age >65 (40% increase in AUC), hepatic impairment (e.g., cirrhosis, 80%), severe renal impairment (creatinine clearance <30 mL/min, 100%), and concomitant use of potent cytochrome P450 3A4 inhibitors [ketoconazole, itraconazole, erythromycin (182%), saquinavir (210%)]. Since higher plasma levels may increase both the efficacy and incidence of adverse events, a starting dose of 25 mg should be considered in these patients. Ritonavir greatly increased the systemic level of sildenafil in a study of healthy, non-HIV infected volunteers (11-fold increase in AUC, see .) Based on these pharmacokinetic data, it is recommended not to exceed a maximum single dose of 25 mg of Viagra in a 48 hour period. Viagra was shown to potentiate the hypotensive effects of nitrates and its administration in patients who use nitric oxide donors or nitrates in any form is therefore contraindicated. When Viagra is co-administered with an alpha-blocker, patients should be stable on alpha-blocker therapy prior to initiating Viagra treatment and Viagra should be initiated at the lowest dose (see ). Viagra (sildenafil citrate) is supplied as blue, film-coated, rounded-diamond-shaped tablets containing sildenafil citrate equivalent to the nominally indicated amount of sildenafil as follows: Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature]. LAB-0221-8.0 ®. It is not meant to take the place of your doctor's instructions. Read this information carefully before you start taking Viagra. Ask your doctor or pharmacist if you do not understand any of this information or if you want to know more about Viagra. This medicine can help many men when it is used as prescribed by their doctors. However, Viagra is not for everyone. It is intended for use only by men who have a condition called erectile dysfunction. Viagra must never be used by men who are taking medicines that contain nitrates of any kind, at any time. This includes nitroglycerin. If you take Viagra with any nitrate medicine your blood pressure could suddenly drop to an unsafe or life threatening level. • WHAT IS Viagra? Viagra is a pill used to treat erectile dysfunction (impotence) in men. It can help many men who have erectile dysfunction get and keep an erection when they become sexually excited (stimulated). You will not get an erection just by taking this medicine. Viagra helps a man with erectile dysfunction get an erection only when he is sexually excited. When a man is sexually excited, the penis rapidly fills with more blood than usual. The penis then expands and hardens. This is called an erection. After the man is done having sex, this extra blood flows out of the penis back into the body. The erection goes away. If an erection lasts for a long time (more than 6 hours), it can permanently damage your penis. You should call a doctor immediately if you ever have a prolonged erection that lasts more than 4 hours. Some conditions and medicines interfere with this natural erection process. The penis cannot fill with enough blood. The man cannot have an erection. This is called erectile dysfunction if it becomes a frequent problem. During sex, your heart works harder. Therefore sexual activity may not be advisable for people who have heart problems. Before you start any treatment for erectile dysfunction, ask your doctor if your heart is healthy enough to handle the extra strain of having sex. If you have chest pains, dizziness or nausea during sex, stop having sex and immediately tell your doctor you have had this problem. Viagra enables many men with erectile dysfunction to respond to sexual stimulation. When a man is sexually excited, Viagra helps the penis fill with enough blood to cause an erection. After sex is over, the erection goes away. As noted above (How Sex Affects the Body), ask your doctor if your heart is healthy enough for sexual activity. If you take any medicines that contain nitrates – either regularly or as needed – you should never take Viagra. If you take Viagra with any nitrate medicine or recreational drug containing nitrates, your blood pressure could suddenly drop to an unsafe level. You could get dizzy, faint, or even have a heart attack or stroke. Nitrates are found in many prescription medicines that are used to treat angina (chest pain due to heart disease) such as: nitroglycerin (sprays, ointments, skin patches or pastes, and tablets that are swallowed or dissolved in the mouth) isosorbide mononitrate and isosorbide dinitrate (tablets that are swallowed, chewed, or dissolved in the mouth) Nitrates are also found in recreational drugs such as amyl nitrate or nitrite ("poppers"). If you are not sure if any of your medicines contain nitrates, or if you do not understand what nitrates are, ask your doctor or pharmacist. Viagra is only for patients with erectile dysfunction. Viagra is not for newborns, children, or women. Do not let anyone else take your Viagra. Viagra must be used only under a doctor's supervision. Viagra does not cure erectile dysfunction. It is a treatment for erectile dysfunction. Viagra does not protect you or your partner from getting sexually transmitted diseases, including HIV—the virus that causes AIDS. Viagra is not a hormone or an aphrodisiac. Only your doctor can decide if Viagra is right for you. Viagra can cause mild, temporary lowering of your blood pressure. You will need to have a thorough medical exam to diagnose your erectile dysfunction and to find out if you can safely take Viagra alone or with your other medicines. Your doctor should determine if your heart is healthy enough to handle the extra strain of having sex. have ever had any heart problems (e.g., angina, chest pain, heart failure, irregular heart beats, heart attack or narrowing of the aortic valve) have ever had any blood problems, including sickle cell anemia or leukemia have a deformed penis, Peyronie's disease, or ever had an erection that lasted more than 4 hours Some medicines can change the way Viagra works. Tell your doctor about any medicines you are taking. Do not start or stop taking any medicines before checking with your doctor or pharmacist. This includes prescription and nonprescription medicines or remedies: Remember, Viagra should never be used with medicines that contain nitrates (see Viagra Is Not for Everyone). If you are taking medicines called alpha-blockers for the treatment of high blood pressure or prostate problems, your blood pressure could suddenly drop. You could get dizzy or faint. If you are taking a protease inhibitor, your dose may be adjusted (please see Finding the Right Dose for You). Viagra should not be used with any other medical treatments that cause erections. These treatments include pills, medicines that are injected or inserted into the penis, implants or vacuum pumps. Viagra comes in different doses (25 mg, 50 mg and 100 mg). If you do not get the results you expect, talk with your doctor. You and your doctor can determine the dose that works best for you. Do not take more Viagra than your doctor prescribes. If you think you need a larger dose of Viagra, check with your doctor. Viagra should not be taken more than once a day. Your doctor may prescribe a lower dose of Viagra in certain circumstances. For example: If you are older than age 65, or have serious liver or kidney problems, your doctor may start you at the lowest dose (25 mg) of Viagra. If you are taking protease inhibitors, such as for the treatment of HIV, your doctor may recommend a 25 mg dose and may limit you to a maximum single dose of 25 mg of Viagra in a 48 hour period. If you have prostate problems or high blood pressure for which you take medicines called alpha blockers, your doctor may start you on a lower dose of Viagra. Take Viagra about one hour before you plan to have sex. Beginning in about 30 minutes and for up to 4 hours, Viagra can help you get an erection if you are sexually excited. If you take Viagra after a high-fat meal (such as a cheeseburger and french fries), the medicine may take a little longer to start working. Viagra can help you get an erection when you are sexually excited. You will not get an erection just by taking the pill. Like all medicines, Viagra can cause some side effects. These effects are usually mild to moderate and usually don't last longer than a few hours. Some of these side effects are more likely to occur with higher doses. The most common side effects of Viagra are headache, flushing of the face, and upset stomach. Less common side effects that may occur are temporary changes in color vision (such as trouble telling the difference between blue and green objects or having a blue color tinge to them), eyes being more sensitive to light, or blurred vision. In rare instances, men taking PDE5 inhibitors (oral erectile dysfunction medicines, including Viagra) reported a sudden decrease or loss of vision in one or both eyes. It is not possible to determine whether these events are related directly to these medicines, to other factors such as high blood pressure or diabetes, or to a combination of these. If you experience sudden decrease or loss of vision, stop taking PDE5 inhibitors, including Viagra, and call a doctor right away. In rare instances, men have reported an erection that lasts many hours. You should call a doctor immediately if you ever have an erection that lasts more than 4 hours. If not treated right away, permanent damage to your penis could occur (see How Sex Affects the Body). Sudden loss or decrease in hearing, sometimes with ringing in the ears and dizziness, has been rarely reported in people taking PDE5 inhibitors, including Viagra. It is not possible to determine whether these events are related directly to the PDE5 inhibitors, to other diseases or medications, to other factors, or to a combination of factors. If you experience these symptoms, stop taking Viagra and contact a doctor right away. Heart attack, stroke, irregular heart beats, and death have been reported rarely in men taking Viagra. Most, but not all, of these men had heart problems before taking this medicine. It is not possible to determine whether these events were directly related to Viagra. Viagra may cause other side effects besides those listed on this sheet. If you want more information or develop any side effects or symptoms you are concerned about, call your doctor. In case of accidental overdose, call your doctor right away. Keep Viagra out of the reach of children. Keep Viagra in its original container. Store at 25°C (77°F); excursions permitted to 15–30°C (59–86°F) [see USP Controlled Room Temperature]. Viagra is a prescription medicine used to treat erectile dysfunction. Only your doctor can decide if it is right for you. This sheet is only a summary. If you have any questions or want more information about Viagra, talk with your doctor or pharmacist, visit www.Viagra.com, or call 1-888-4Viagra. LAB-0220-6.0
viagra cheapest generic substitute
When we speak of sex drive problems, or dysfunction, we automatically think of males and erectile dysfunction, and omit women from the equation. However, many women experience problems with their �libido' or sexual energy, and this phenomena deserves attention too. Viagra is the most common treatment for erectile dysfunction in males, and has traditionally been recommended for men only, women being advised not to use it. So the main reason for this is lack of empirical research stating otherwise, which is due to the absence of definitive studies on women. Viagra however can work for women, as it increases the blood flow to a woman's genitals (much the same way as with a man's), which boosts their libido. There are important considerations however, which shall be listed below. As Viagra is aimed at men's erectile dysfunction, women are unable to obtain a prescription and buy Viagra from a pharmaceutical store. However generic versions are available on the internet, but as so many are on the market, if in doubt contact the supplier as to whether a product is available. When buying from online pharmacies, it is possible to check their pharmacy ID if concerned about legitimacy. It is important for women to take into consideration possible side effects of Viagra, although not widespread there is still a possibility of them occurring. For instance, some Viagra users have reported dizziness, flushing, loss of vision, and so on. Check all possible side effects before commencing use. Furthermore, Viagra should not be taken alongside any nitrate medicines as this can cause abnormally low blood pressure, so always check! Women, who suffer with a low sex drive often, should seek a long term cure other then Viagra in order to increase their libido and have a permanent effect. Long term Viagra use can result in expense, so if the problem continues regularly, even after Viagra use, women should aim to seek other remedial methods. 5mexican sildenafil citrate Nuts, crocodiles and witch trials may seem to have little to do with Viagra -- but at one time or another, they've all been employed against erectile dysfunction. For centuries, doctors struggled to pinpoint the causes of male impotence, blaming such factors as stress, diet, the wrath of deities and unattractive women. Ancient Greek physician Hippocrates attributed impotence to horseback riding; one of his contemporaries placed the blame on childhood trauma; Egyptians to evil spells. The ancients also left behind an imaginative array of remedies: snacks of almonds, pistachios, dates, currant juice and bird eggs in Persia; a mix of sesame, lentils, rice and sugar cane juice in ancient India -- or goat testicles boiled in milk or butter and boiled alligator testes rubbed on the feet. The Egyptians were more direct, smearing remedies (such as crocodile hearts and wood oil) directly on the penis. In the Islamic empire, impotence was sometimes blamed on an imbalance in the four fluids, or humors, thought to course through the body. Doctors advised men to avoid sex after meals, in the bathroom and with old or unappealing partners. In medieval Europe, impotent men believed they were under spells cast by witches, but also blamed their wives. Impotence was grounds for divorce. In the Victorian era, many thought impotence was due to a depletion of sperm. Doctors cautioned against masturbation (a "waste" of sperm) and prescribed quinine, opium, digitalis and bleeding, to no avail. In the late 1800s, French professor of medicine Charles Edouard Brown-Sequard proposed that injections of animal sperm might restore vitality. He tested the theory by injecting himself with an extract of dog and guinea pig testicles. His colleagues, who agreed the professor looked good for a man of 72, agreed to test the extracts on their patients. Soon the treatment, organotherapy, was all the rage. Starting in the late 1910s, a few doctors went a step further, deciding to transplant whole testicles. In France, Serge Voronoff transplanted monkey testicles into the nether regions of more than 1,000 old men. In Kansas, John Brinkley ran a hospital that specialized in grafting goat testicles onto patients. At a California prison, Leo Stanley gave older inmates testicles of younger, executed prisoners. Although many men claimed to feel rejuvenated by their testicular shots and transplants, few recovered their virility, and researchers continued their search. In the 1930s doctors experimented with surgical adjustment of penile muscles. In the 1940s and 1950s, they tried implants, inspired by the penile bones many animals have. In the 1960s, an effective option finally arrived. A Georgia tire serviceman began work on a vacuum pump to treat his own impotence, which was ultimately approved by the Food and Drug Administration in 1982. The pump appeared just as several researchers began to identify drug treatments for impotence, albeit few with the showmanship exhibited by British doctor Giles Brindley. At a 1983 urology meeting, Brindley injected himself with a drug, phentolamine -- then took the stage, dropped his pants and shared his erection with his colleagues. Brindley injected 33 drugs in his penis before finding one that worked, which may have rendered him slightly envious of the discoverers of Viagra. British researchers Ian Osterloh and Gill Samuels were developing a drug to improve blood flow to the heart when they realized that the drug, sildenafil citrate, was much more effective at improving blood flow to the penis -- and causing erections. In Viagra's first month on the market, doctors wrote well over 500,000 prescriptions. Considering men's history of options -- crocodile hearts, prayer, testicular shots and grafts -- perhaps the blue pill's lasting popularity should come as no surprise.

foreign generic viagra

Nuts, crocodiles and witch trials may seem to have little to do with Viagra -- but at one time or another, they've all been employed against erectile dysfunction. For centuries, doctors struggled to pinpoint the causes of male impotence, blaming such factors as stress, diet, the wrath of deities and unattractive women. Ancient Greek physician Hippocrates attributed impotence to horseback riding; one of his contemporaries placed the blame on childhood trauma; Egyptians to evil spells. The ancients also left behind an imaginative array of remedies: snacks of almonds, pistachios, dates, currant juice and bird eggs in Persia; a mix of sesame, lentils, rice and sugar cane juice in ancient India -- or goat testicles boiled in milk or butter and boiled alligator testes rubbed on the feet. The Egyptians were more direct, smearing remedies (such as crocodile hearts and wood oil) directly on the penis. In the Islamic empire, impotence was sometimes blamed on an imbalance in the four fluids, or humors, thought to course through the body. Doctors advised men to avoid sex after meals, in the bathroom and with old or unappealing partners. In medieval Europe, impotent men believed they were under spells cast by witches, but also blamed their wives. Impotence was grounds for divorce. In the Victorian era, many thought impotence was due to a depletion of sperm. Doctors cautioned against masturbation (a "waste" of sperm) and prescribed quinine, opium, digitalis and bleeding, to no avail. In the late 1800s, French professor of medicine Charles Edouard Brown-Sequard proposed that injections of animal sperm might restore vitality. He tested the theory by injecting himself with an extract of dog and guinea pig testicles. His colleagues, who agreed the professor looked good for a man of 72, agreed to test the extracts on their patients. Soon the treatment, organotherapy, was all the rage. Starting in the late 1910s, a few doctors went a step further, deciding to transplant whole testicles. In France, Serge Voronoff transplanted monkey testicles into the nether regions of more than 1,000 old men. In Kansas, John Brinkley ran a hospital that specialized in grafting goat testicles onto patients. At a California prison, Leo Stanley gave older inmates testicles of younger, executed prisoners. Although many men claimed to feel rejuvenated by their testicular shots and transplants, few recovered their virility, and researchers continued their search. In the 1930s doctors experimented with surgical adjustment of penile muscles. In the 1940s and 1950s, they tried implants, inspired by the penile bones many animals have. In the 1960s, an effective option finally arrived. A Georgia tire serviceman began work on a vacuum pump to treat his own impotence, which was ultimately approved by the Food and Drug Administration in 1982. The pump appeared just as several researchers began to identify drug treatments for impotence, albeit few with the showmanship exhibited by British doctor Giles Brindley. At a 1983 urology meeting, Brindley injected himself with a drug, phentolamine -- then took the stage, dropped his pants and shared his erection with his colleagues. Brindley injected 33 drugs in his penis before finding one that worked, which may have rendered him slightly envious of the discoverers of Viagra. British researchers Ian Osterloh and Gill Samuels were developing a drug to improve blood flow to the heart when they realized that the drug, sildenafil citrate, was much more effective at improving blood flow to the penis -- and causing erections. In Viagra's first month on the market, doctors wrote well over 500,000 prescriptions. Considering men's history of options -- crocodile hearts, prayer, testicular shots and grafts -- perhaps the blue pill's lasting popularity should come as no surprise. What is Viagra used for? Viagra is used to treat impotence in men. Viagra increases the body’s ability to achieve and maintain an erection during sexual stimulation. Viagra does not protect you from getting sexually transmitted diseases, including HIV. take Viagra? Men who are currently using medicines that contain nitrates, such as nitroglycerin should not use Viagra because taken together they can lower the blood pressure too much. Viagra should not be used by women or children. In patients taking Viagra, several heart-related side effects have been reported, including heart attack, sudden death, irregular heart rhythm, stroke, chest pain, and increased blood pressure. It is not possible to determine whether these events are directly related to Viagra, to sexual activity, to the patient’s heart condition, to a combination of these factors, or to other factors. taking certain medications at the same time (e.g., ketoconazole, itraconazole, erythromycin and saquinavir). In these patients, the recommended starting dose of Viagra is 25 mg. Heart attack, stroke, or life-threatening irregular heart rhythm within the last 6 months Because Viagra lowers blood pressure, your doctor will evaluate your overall medical condition to determine if Viagra, in combination with sexual activity, could adversely affect you. Viagra can cause a rare but serious condition of prolonged erection (priapism). It is important to contact your health care provider immediately if your erection lasts longer than 4 hours. Men for whom sexual activity is inadvisable may not be good candidates for Viagra. Tell your doctor if you are taking protease inhibitors for the treatment of HIV. You should have a complete medical history and exam to determine the cause of your impotence before taking Viagra. Men who have medical conditions that may cause a sustained erection such as sickle cell anemia, leukemia or multiple myeloma or who have an abnormally shaped penis may not be able to take Viagra. There are several medications that are known to interact with Viagra, so be sure to tell your doctor about all medications you are taking including those you can get without a prescription. Viagra has not been studied with other treatments for impotence, so use in combination with other treatments is not recommended. What are some possible side effects of Viagra? a complete list of side effects reported with Viagra. Your health care provider can discuss with you a more complete list of side effects.) ). The following is a listing of the most common side effects Visual changes such as mild and temporary changes in blue/green colors or increased sensitivity to light. For more detailed information about Viagra, ask your health care provider. levitra cialis viagra comparison Viagra receives much cynicism about its effects and usefulness, despite the facts that all the evidence suggests otherwise, and there are thousands of satisfied users world wide. Most generally acknowledged as a cure for male erectile dysfunction, it has been documented that Viagra does more than just aid a man's erection. Various reports from numerous areas of health research worldwide point to other possible health benefits of Viagra. For instance, Saarland discovered that Viagra can reduce symptoms of Raynaud's phenomenon, a circulatory disorder. The hormonal stress normally exerted on the human heart has been noted to be decreased in men who take Viagra. When conducted with mice, the testing was more noticeable, Viagra having the tendency to avert harmful and long term effects of chronic hypertension on their heart. The study, lead by the John Hopkins research team, found that there is potential benefits for the treatment of pulmonary hypertension, linked in with how viagra dilates genital blood vessels. After testing on humans, abnormally high heart rates appeared to reduce by 50% after taking sildenafil (Viagra). Current evidence indicates health benefits of Viagra, in addition to the most commonly associated benefit of curing erectile dysfunction.

viagra cialis generic

Viagra turns 10 this month, and didn't time just fly? It seems like only yesterday we started guffawing at the Symbolism for Dummies ads on TV for the little blue pill and its "erectile dysfunction" rivals -- footballs tossed through tires, faucets erupting. The spots ended with a list of potential side effects that sounded like a satire of potential side effects. "More than four hours?" we winced. "Ouch." However discomfiting the commercials, the Food and Drug Administration (FDA) approval of Viagra -- on March 27, 1998 -- is a landmark day in the history of sex. It seemed at the time like a biomedical revolution was upon us all, and about five minutes after word of the magical med went global, the question first was asked: Where is the women's version of Viagra? The short answer: They're still working on it. A bunch of companies have tried and failed to create "pink Viagra," as it's often called. Other companies have drugs in late stages of clinical testing, including a gel that recently began a make-or-break nationwide study with several thousand women. Give us five years, maybe less, say the most optimistic researchers and doctors. Though it's unclear exactly how many women would ask for a prescription, no one doubts that the first company that gets to market a remedy for female sexual dysfunction (FSD), as it's formally known, will earn a fortune. But as this race reaches what could be its final lap, not all of the spectators are cheering. Some, in fact, are booing as loudly as they can. A modest-size but fervent group of psychologists, academics and public health advocates contend that FSD isn't an authentic medical condition, or at least not the sort of problem that should be treated with drugs. These aren't the obtuse male physicians who for decades have been telling women distressed by their lack of libido that "it's all in your head." The anti-FSD crowd is mostly women, many of them self-described feminists. The most prominent is Leonore Tiefer, a psychotherapist and clinical associate professor at New York University, who has long decried what she calls "the medicalization of women's sexuality." "Drug companies want to say to women, 'You don't need to know anything; you can have the satisfying sex life that you seek -- people dancing on TV, the whole bit -- without knowing anything. Just ask your doctor,' " she says. "I resent that, because there are specific harms that come from being ignorant and dependent in the world we live in. There may be lots of people who aren't interested in sex, but is there a medical reason for that, and do we diagnose that?" 220 1 sildenafil citrate Levitra and Viagra are different drugs used to treat one common issue, Erectile Dysfunction (impotence). There are lots of similarities as well as differences when looking at Levitra vs. Viagra. Advice from your health care provider is the ideal way to conclude which drug is the perfect choice for treating your ED. One should never diagnose and treat ED on their own; it could turn out to be a life threatening move. It is mandatory for men with ED to understand the fact that they are not alone. As a matter of fact, millions of men all over the world suffer from ED each year. Fortunately, advancement in pharmaceutical technology has offered choices for these millions. When comparing Levitra with Viagra, the main point of difference is the main ingredient. While Levitra’s main ingredient consists of vardenfil, a PDE5 inhibitor, the main ingredient in Viagra is sildenafil citrate, which has been used not only to treat ED, but also pulmonary arterial hypertension Side effects arising from the use of vardenfil are: abdominal pain, back pain, photosensitivity, abnormal vision, eye pain, facial edema, hypertension, palpitation, tachycardia, arthralgia, myalgia, rash, itch, priapism, and in a few rare scenarios heart attack. Vardenfil should also not be taken if the patient is using any sort of nitrate medication. This is because it has the tendency to produce very low blood pressure. Health care providers will never prescribe Levitra to a patient at risk of experiencing serious side effects. Viagra was the first pill to be introduced to the market. Side effects of Viagra include: priapism, severe hypotension, myocardial infarction, ventricular arrhythmias, sudden death, stroke and enhanced intraocular pressure. The common side effects consist of sneezing, headache, flushing, dyspepsia, prolonged erections, palpitations, and photophobia. Visual changes including blurring of vision and a curious bluish tinge which have been reported in studies. Levitra and Viagra are nearly identical in that they are to be consumed anywhere from a half an hour to a couple of hours prior to sexual activity. Viagra may have been the starting point in the treatment of ED, but there is no doubt that Levitra has been seen as “new and better”. Levitra’s side effects are far and few versus Viagra, though response of drugs varies from person to person. A detailed analysis of your medical history is required to choose the ideal prescription drug for you. mail order viagra in uk generic viagra sale There is no foolproof evidence of Viagra not working on women, but according to research carried out on 577 women who had issues with sexual arousal for a time period of at least six months, it has been established that Viagra is not very effective in women. This is because sexual difficulties in women are complex in nature. The women took 10, 50 or 100 milligrams of Viagra one hour before sex for three months. The researchers came to the conclusion that Viagra did not make any sort of difference in terms of greater sexual arousal even though Viagra does enhance blood flow to the woman's genital portion. People are of the view that Viagra does not work on women because they are altogether different from man in terms of their objectives, desires, emotions and at the biochemical level. Female sexuality is quite complex compared to male sexuality so even after wide array of scientific research involving about 3,000 women, Pfizer has not been able to come up with authentic findings. Not so long ago, Pfizer publicly announced in the media that they are completing research of Viagra in women. That does not mean there is no any ray of hope for women. Research is going on continuously in a number of other products for the female libido. Research on postmenopausal women on Viagra has come to the conclusion that the Viagra did have some bearing on the blood flow to the clitoris (quite a number of times uncomfortably so) but did not assist any of the women in getting aroused or feeling more at ease during sex. The multicenter research, which was conducted in Canada, various cities of Europe, and Australia, consists of pre-menopausal and postmenopausal women who have opted for hormone replacement therapy and have been diagnosed with female sexual arousal disorder, a category that falls under the broad umbrella of sexual dysfunction. Interestingly, around twenty eight percent 28% of the women reported hypoactive sexual desire disorder as the main symptom. 17% of the women complained of female orgasmic disorder. 9% women were facing issues due to dyspareunia. A wide array of sexual complaints may have played a prominent role in watering down the effectiveness of Viagra. Only a small chunk of women suffering with sexual dysfunction have poor genital feedback without any issues involving libido or mental arousal. Yet those are the sorts of patients who should get an advantage from taking Viagra. That is where future research will study subgroups of women with arousal disorder, especially those who suffer difficulty in getting extra blood to the front portion of the vagina during sex. buy generic viagra cheap Viagra is one of the few prescription drugs that require almost no publicity. You can find news stories, detailed description and jokes in print, on television and on the internet. Sexual dysfunction is a very serious issue for those who are suffering as well as for their partners. After years without the ability to enjoy sexual intimacy, it is no surprise that lots of people all over the globe are ready to try Viagra. Though the drug that is capable of restoring penile erectile functions, it has wide array of medical, economic and social problems attached. Older users with severe heart disease may experience side effects which can lead to death and the chemical effects of Viagra are also life threatening. Additionally, adverse social effects of Viagra use have also come into the fray in various media circles. There are newspaper reports that say the lives of older couples are being ruined because of Viagra. Men are leaving longstanding relationships for younger women and there are cases of assault on women because of their lack of response to a partner’s new sexual routine. The normal dose of Viagra is 50 mg taken about an hour prior to the expected sex act, though the medication is effective even if taken four hours prior to sex. It is of paramount importance that the next dose not be used until after a day has passed from the last intake. Most importantly, patients with liver or kidney disease should take lower dosages (25 mg) due to their lower ability to eliminate the drug. The most basic reactions with the use of Viagra are headaches, flushing, indigestion and nasal congestion. These sorts of reactions occur in 4% - 16% of patients taking Viagra. Most of the adverse reactions are mild in nature and quite well handled by healthy individuals. While it cannot be termed as an adverse reaction, the new-found sexual prowess can lead older males with underlying medical issues such as heart disease to exert themselves more than they have in recent years. This can precipitate a heart attack or other acute medical emergency. According to one study, the Food and Drug Administration has reported sixteen deaths that followed the use of Viagra. All of these deaths occurred in individuals sixty years and older suffering from of heart disease, hypertension or diabetes. The use of Viagra may lead to stress and marital discord which can result in divorce and the need for psychological counseling. Apart from that, the enhanced sexual routine may also give rise to sexually transmitted diseases and AIDS in older individuals who would not normally be exposed.
where can i order generic viagra
The most widely used remedy for erectile dysfunction; research has indicated that Viagra has an effect on the condition of the human heart as well as a male's penis. The hormonal stress normally exerted on the human heart has been noted to be decreased in men who take Viagra. When conducted with mice, the testing was more noticeable, Viagra having the tendency to avert harmful and long term effects of chronic hypertension on their heart. The study, lead by the John Hopkins research team, found that there is potential benefits for the treatment of pulmonary hypertension, linked in with how Viagra dilates genital blood vessels. Viagra works by dulling the heart beat, which is increased during stress. It works to decrease the force which is needed to pump blood from the heart to the rest of the body. The research conducted by David Kass, cardiologist and senior researcher of the John Hopkins study noticed Viagra can be effective in blocking short- term consequences of hormonal stresses in the heart. Further evidence on the testing of mice (although further research is needed until this is applicable to humans), indicated that negative effects of heart failure and cardiac hypertrophy on weakened heart muscles can be reversed. Further research is need in this area on humans however. Thirty five men and women were tested and injected with Dobutamine (a synthetic derivative of dopamine that increases heart rate and contractions), which resulted in increased rate of 150%. The men and women were then separated into two groups, one of which were given sildenafil (Viagra) and the other given a placebo (fake) pill. Results showed that the first group's heart rate decreased by 50%, whilst the latter group's further increased. This has led to widespread scientific interest in the effects of sildenafil (Viagra) on the human heart condition. citrate generic sildenafil viagra Erectile dysfunction in men is a common problem, even more so in men over the age of 45. different lifestyle traits can contribute to erectile dysfunction, however Viagra is the most commonly used cure for impotence and erectile dysfunction. It is not necessarily the case that men naturally experience a lower sexual drive or erectile dysfunction when they reach a certain age. A man's inability to gain and sustain an erection may be due more to abnormalities in treatable physical conditions. In 1983, Dr Giles Brindley made the discovery and demonstrated that a penis could be made erect by injecting it with the drug Phentolamine. He discovered the penis could be mad erect by relaxing the normally constricted blood vessels. Once the vessels are relaxed, they let increased blood into the penis, which then inflates to form an erection. Two problems however were soon recognised. Phentolamine is not selective enough to target only the penis to inflate and can unpredictably effect other parts of the body. Secondly, the erection is not brought on by sexual stimulation and a man will continue to have an erection until the drug wears off. Viagra combats such drawbacks however. It works by enhancing the natural process that occurs when a man is sexually stimulated. Viagra controls what we might call �softeners'- chemicals in the body designed to make the penis soften after an erection has occurred. When a man is sexually stimulated chemicals in the body relax the blood vessels in his penis and increase the blood flow. At the same time the body also produces phosphodiesterase (PDE5), which work to subside the erection afterwards. Erectile dysfunction is an imbalance which results in the inability of a male to sustain an erection. Viagra reduced such �softeners', allowing blood flow to the penis to create sustainable erections. Viagra does not take the place of stimulation but increases the effects of stimulation. After the Viagra has worn off (usually 4 or 5 hours later), the normal processes are restored to how they were prior to taking Viagra. Possible side effects can occur, such as flushing and dizziness, and if an individual experiences these, they should consult a doctor. viagra pills online

5 mg sildenafil citrate hypertension pulmonary sildenafil

A consistent inability to sustain an erection sufficient for sexual intercourse. Also commonly known as impotence. Medically, the term erectile dysfunction is used to differentiate impotence from other problems that interfere with sexual intercourse The following drugs and medications are in some way related to, or used in the treatment of Impotence. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners..
The truth is that these herbal viagra alternatives work. the most important feature of these herbal medications for erectile dysfunction is that they don’t exhibit negative side effects unlike viagra. why pay âĽ12-âĽ15 per tablet via your doctor’s prescription? you can now get 4 x genuine 100mg (double strength!) viagra tablets direct at these low low prices! genuine 100mg (double strength!) viagra tablets give you rock hard erections every time! you just take half a tablet 30-60 minutes before any sexual activity. (this gives you 8 total doses!) we have this product in stock sealed, hologrammed boxes of 4 x viagra 100mg. regain your sex life! thousands of men have regained their sex life with the use of this product. viagra works in as little as 60 minutes and its effects last up to six hours. you don’t have to wait anymore to get back in the swing of life.you have a choice. viagra improves erections for men from ages 18-90 and is 98% effective we guarantee it! money back guarantee if not 100% satisfied. all orders received before 2pm gmt will be dispatched same day from the uk. postage is free. why pay âĽ20 per tablet via your doctor’s prescription? you can now get 4 x genuine 20mg (double strength!) cialis tablets direct at these low low prices! genuine 20mg (double strength!) cialis tablets give you rock hard erections every time! you just take half a tablet 30-60 minutes before any sexual activity. (this gives you 8 total doses!) we have this product in stock sealed, hologrammed boxes of 4 x cialis 20mg. expiry date is december 2010. regain your sex life! cialis 20mg is the first tablet for erectile dysfunction (ed) that gives you up to 36 hours to choose the moment that’s right for you and your partner. cialis works fast - within 30 minutes in some patients - and can work up to 36 hours. that means you and your partner can be spontaneous, responding to each other sexually when the moment is right. of course results may vary. we guarantee it! money back guarantee if not 100% satisfied. all orders received before 2pm gmt will be dispatched same day from the uk. postage is free. sales genuine viagra why pay âĽ20 per tablet via your doctor’s prescription? you can now get 4 x genuine 20mg (double strength!) cialis tablets direct at these low low prices! genuine 20mg (double strength!) cialis tablets give you rock hard erections every time! you just take half a tablet 30-60 minutes before any sexual activity. (this gives you 8 total doses!) we have this product in stock sealed, hologrammed boxes of 4 x cialis 20mg. expiry date is december 2010. how about side effect of this viagra? There is no foolproof evidence of Viagra not working on women, but according to research carried out on 577 women who had issues with sexual arousal for a time period of at least six months, it has been established that Viagra is not very effective in women. This is because sexual difficulties in women are complex in nature. The women took 10, 50 or 100 milligrams of Viagra one hour before sex for three months. The researchers came to the conclusion that Viagra did not make any sort of difference in terms of greater sexual arousal even though Viagra does enhance blood flow to the woman's genital portion. People are of the view that Viagra does not work on women because they are altogether different from man in terms of their objectives, desires, emotions and at the biochemical level. Female sexuality is quite complex compared to male sexuality so even after wide array of scientific research involving about 3,000 women, Pfizer has not been able to come up with authentic findings. Not so long ago, Pfizer publicly announced in the media that they are completing research of Viagra in women. That does not mean there is no any ray of hope for women. Research is going on continuously in a number of other products for the female libido. Research on postmenopausal women on Viagra has come to the conclusion that the Viagra did have some bearing on the blood flow to the clitoris (quite a number of times uncomfortably so) but did not assist any of the women in getting aroused or feeling more at ease during sex. The multicenter research, which was conducted in Canada, various cities of Europe, and Australia, consists of pre-menopausal and postmenopausal women who have opted for hormone replacement therapy and have been diagnosed with female sexual arousal disorder, a category that falls under the broad umbrella of sexual dysfunction. Interestingly, around twenty eight percent 28% of the women reported hypoactive sexual desire disorder as the main symptom. 17% of the women complained of female orgasmic disorder. 9% women were facing issues due to dyspareunia. A wide array of sexual complaints may have played a prominent role in watering down the effectiveness of Viagra. Only a small chunk of women suffering with sexual dysfunction have poor genital feedback without any issues involving libido or mental arousal. Yet those are the sorts of patients who should get an advantage from taking Viagra. That is where future research will study subgroups of women with arousal disorder, especially those who suffer difficulty in getting extra blood to the front portion of the vagina during sex..
Lifestyle drugs are medicines that treat conditions attached with lifestyle like weight loss tablets, anti-smoking agents, impotence therapies and hair restorers. according to one statistic, companies have invested over $20 billion in research into such drugs since the 1990s and are expected to increase that amount in the coming years. because impotence is normally termed as an annoyance rather than a real threat to health, the drugs (in this case viagra) that treat it are frequently called "lifestyle drugs, though potential new applications could give these compounds lifesaving medical roles in near future. everyone is talking about viagra these days. tv shows are interviewing ecstatic customers while newspapers and magazines are analyzing its cultural implications. the internet is spreading information on how to get it, bars and cocktail parties are buzzing with jokes about it. viagra is more than just a blockbuster drug that treats a widespread sexual ailment, it demonstrates a whole new type of drug that will have bearing on the lifestyle of millions. viagra is a godsend for men with clinically diagnosed impotence. it is similar to weight loss drugs can be a prominent health boon for the seriously obese. the pivotal factor behind the vast appeal of such drugs is their ability to improve the lives of people with less than severe symptoms. interestingly, many in the viagra target audience are sexually potent men who are interested in increasing sexual performance. the new lifestyle drugs could turn the pharmaceutical industry into an engine of growth. global spending on pharmaceuticals is running at about $300 billion annually. at a time when people lay out $25 to $30 a month on cable television, it seems a distinct possibility that they will be willing to pay as much for a lifestyle drug. such spending could increase the range of the drug industry in new few years, sending ripple effects through the whole economy. pfizer's competitors are working overtime to improve on viagra. the drug started its popularity as a potential angina treatment that, but it also suppressed an important enzyme, giving rise to a firm, sustained erection. the main challenge for competitors of viagra is to develop medicines that do not produce the side effects of viagra, which include headache and a blue haze in the patient's vision. the speedy entrance of competing drugs highlights the fact that technology is helping the pharmaceutical industry. not so long ago, making of new drug would take around 15 years but at present one can make a new drug in the matter of few years. Levitra and Viagra are different drugs used to treat one common issue, Erectile Dysfunction (impotence). There are lots of similarities as well as differences when looking at Levitra vs. Viagra. Advice from your health care provider is the ideal way to conclude which drug is the perfect choice for treating your ED. One should never diagnose and treat ED on their own; it could turn out to be a life threatening move. It is mandatory for men with ED to understand the fact that they are not alone. As a matter of fact, millions of men all over the world suffer from ED each year. Fortunately, advancement in pharmaceutical technology has offered choices for these millions. When comparing Levitra with Viagra, the main point of difference is the main ingredient. While Levitra’s main ingredient consists of vardenfil, a PDE5 inhibitor, the main ingredient in Viagra is sildenafil citrate, which has been used not only to treat ED, but also pulmonary arterial hypertension Side effects arising from the use of vardenfil are: abdominal pain, back pain, photosensitivity, abnormal vision, eye pain, facial edema, hypertension, palpitation, tachycardia, arthralgia, myalgia, rash, itch, priapism, and in a few rare scenarios heart attack. Vardenfil should also not be taken if the patient is using any sort of nitrate medication. This is because it has the tendency to produce very low blood pressure. Health care providers will never prescribe Levitra to a patient at risk of experiencing serious side effects. Viagra was the first pill to be introduced to the market. Side effects of Viagra include: priapism, severe hypotension, myocardial infarction, ventricular arrhythmias, sudden death, stroke and enhanced intraocular pressure. The common side effects consist of sneezing, headache, flushing, dyspepsia, prolonged erections, palpitations, and photophobia. Visual changes including blurring of vision and a curious bluish tinge which have been reported in studies. Levitra and Viagra are nearly identical in that they are to be consumed anywhere from a half an hour to a couple of hours prior to sexual activity. Viagra may have been the starting point in the treatment of ED, but there is no doubt that Levitra has been seen as “new and better”. Levitra’s side effects are far and few versus Viagra, though response of drugs varies from person to person. A detailed analysis of your medical history is required to choose the ideal prescription drug for you.sildenafil citrate 100mg plus Before proceeding to buy Viagra, we at UK Medix strongly advise that you read through the following information provided specifically on Viagra. We have provided it to answer all your unanswered questions on the medication, however we do understand that some may slip through and remain unanswered, in this case we would recommend that you seek advice from your prescribing physician or if you obtained your Viagra from UK Medix please feel free to contact our medical team for assistance. Please understand that this is not a comprehensive review of Viagra but a guide compiled by us at UK Medix regarding the use and effects. If any aspect of taking Viagra concerns you ensure to consult with your doctor before ordering. Should you take Viagra? Viagra was developed by Pfizer to treat men in their ongoing quest to tackle Erectile Dysfunction (aka impotence). It is a prescription medication that should only be taken if and when you wish to have sex and it is active only on arousal. This arousal may be physical or visual but either way you will need to be sexually aroused for Viagra to work; how aroused you need to be depends entirely on the patient and their individual degree of erectile dysfunction. At UK Medix, we insist that Viagra is not for female patients and thus should only be taken by men who obtain a prescription. It may be dangerous for females as studies have not been carried out and anyway for female impotence, UK Medix have heard of new medications coming out soon, such as a testosterone patch, currently known as Intrinsa. Viagra was originally developed as a compound to be trialed as just another medication for blood pressure and hypertension, not much excitement there really. However, it was in clinical trials that the scientists at Pfizer realized something that would change the course of sexual history worldwide; the side effects of this medication were that impotent men were getting erections. Eureka! (Quote - Archimedes) So, how exactly does Viagra work? Viagra works by causing the smooth muscles in your blood vessels to relax, increasing blood flow around and lowering the blood pressure. The active ingredient in Viagra, sildenafil, is also a PDE5 inhibitor; and it is this in particular that specifies an increase in blood flow to the penis. When a man is sexually stimulated his penile arteries go through a process to relax and enlarge. As they enlarge, the veins that remove blood from the penis are compressed thus restricting blood flow out of the penis, causing an erection. Although erectile dysfunction was originally thought to be purely psychological, the discovery of Viagra refuted this and it is now common fa